Amber Yates/ LinkedIn
Jun 25, 2026, 15:46
Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
Amber Yates, Senior Medical Director and Global Medical Affairs Leader at Agios Pharmaceuticals, shared a post on LinkedIn:
“A rare day at Agios headquarters, given my remote work, and a meaningful reminder of our shared purpose.
Being in the room with colleagues collectively focused on making a meaningful difference in the lives of people living with sickle cell disease is both energizing and grounding.
Different perspectives, one mission.
Grateful to be part of a work and a team that keeps patients at the center of everything we do.”
Find more posts featuring Amber Yates on Hemostasis Today.
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy
-
Jun 25, 2026, 15:23Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
-
Jun 25, 2026, 15:21Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Jun 25, 2026, 15:06Ifeanyichukwu Ifechidere: What If One of the Biggest Myth Fact About APS is Hidden in its Name?
-
Jun 25, 2026, 15:05Gopal Patidar: Advancing Haemovigilance and Global Collaboration at ISBT 2026
-
Jun 25, 2026, 14:52Violeta Jardin: Measuring Antifibrinolytic Effect to Improve Tranexamic Acid Safety
-
Jun 25, 2026, 14:34Heghine Khachatryan: Hemostasis at the Crossroads of Immunity and Inflammation
-
Jun 25, 2026, 14:30Jean-Jacques Kiladjian: Building the Next Generation of MPN Leaders